Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Epilepsia 2017;58(12):21782185
This engagement leads to improved satisfaction and long-term outcomes
The expressions of fibrosis markers TGF-, CTGF, and Smad 2/3 were significantly up-regulated in the BCNI group
21 Liraglutide showed no effect on the hierarchical primary endpoint of time to death, time to rehospitalisation for HF and time-averaged change in N-terminal pro B-type natriuretic peptide (NT-proBNP) from baseline to 180 days (p=0.31), with even an increased risk of emergency department visit, HF hospitalisation or all-cause death events (HR 1.36
/assets/images/provider/photos/2793649.jpeg)
US$ 28.69
US$ 26.66
US$ 25.09
